Related Experiment Video
Updated: Feb 10, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia
Jun-Ho Cho1, Goo-Young Kim1, Brian C Mansfield1,2
1Section on Cellular Differentiation, Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 8N240C, NIH, 10 Center Drive, Bethesda, MD, 20892-1830, USA.
Glycogen storage disease type Ia (GSD-Ia) involves impaired glucose homeostasis. This study reveals that reduced sirtuin 1 (SIRT1) signaling in GSD-Ia causes mitochondrial dysfunction and DNA damage, potentially leading to liver cancer.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Disorders
Background:
- Glycogen storage disease type Ia (GSD-Ia) is a metabolic disorder affecting glucose homeostasis.
- Hepatocellular adenoma/carcinoma (HCA/HCC) is a long-term complication of GSD-Ia.
- Mitochondrial dysfunction is implicated in GSD-Ia, but mechanisms are unclear.
Purpose of the Study:
- To investigate the role of sirtuin 1 (SIRT1) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) signaling in GSD-Ia.
- To determine the contribution of mitochondrial dysfunction to HCA/HCC development in GSD-Ia.
Main Methods:
- Assessed hepatic SIRT1 and PGC-1α signaling in G6Pase-α-deficient mouse models.
- Analyzed mitochondrial function, including oxidative phosphorylation and electron transport chain components.
- Examined mitochondrial and oxidative DNA damage in HCA/HCC lesions.
Main Results:
- G6Pase-α deficiency downregulated hepatic SIRT1/PGC-1α signaling, leading to impaired mitochondrial function.
- Overexpression of SIRT1 restored PGC-1α activity and mitochondrial function.
- HCA/HCC lesions showed significant mitochondrial and oxidative DNA damage.
Conclusions:
- Downregulation of hepatic SIRT1/PGC-1α signaling is a key mechanism underlying mitochondrial dysfunction in GSD-Ia.
- Mitochondrial dysfunction and subsequent oxidative DNA damage may contribute to HCA/HCC development in GSD-Ia.
More Related Videos
Related Concept Videos
Types of Signaling Molecules
Types of Functions I
Types of Functions II
Animal Mitochondrial Genetics
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Storage

